L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 1, Pages 294
Publisher
MDPI AG
Online
2020-01-03
DOI
10.3390/ijms21010294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia
- (2019) Rhyomi C. Sellnow et al. Acta Neuropathologica Communications
- Neurochemical impact of the 5-HT2C receptor agonist WAY-163909 on monoamine tissue content in the rat brain
- (2019) Abdeslam Chagraoui et al. NEUROCHEMISTRY INTERNATIONAL
- Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson’s Disease Patients
- (2019) Giovanni D’Andrea et al. Scientific Reports
- The TAAR5 agonist α-NETA causes dyskinesia in mice
- (2019) Aleksander A. Aleksandrov et al. NEUROSCIENCE LETTERS
- Distinct gradients of various neurotransmitter markers in caudate nucleus and putamen of the human brain
- (2019) Heide Hörtnagl et al. JOURNAL OF NEUROCHEMISTRY
- l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson’s Disease
- (2019) Yoshio Goshima et al. Frontiers in Pharmacology
- How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study
- (2019) Domen Pregeljc et al. NEUROTOXICITY RESEARCH
- Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites
- (2018) Changliang Liu et al. CELL
- Serotonergic targets for the treatment of l-DOPA-induced dyskinesia
- (2018) Kathryn Lanza et al. JOURNAL OF NEURAL TRANSMISSION
- Signal transduction in l-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression
- (2018) Giada Spigolon et al. JOURNAL OF NEURAL TRANSMISSION
- The serotonergic system in L-DOPA-induced dyskinesia: pre-clinical evidence and clinical perspective
- (2018) Manolo Carta et al. JOURNAL OF NEURAL TRANSMISSION
- Striatal norepinephrine efflux in l -DOPA-induced dyskinesia
- (2018) Corinne Y. Ostock et al. NEUROCHEMISTRY INTERNATIONAL
- Trace Amines and Their Receptors
- (2018) Raul R. Gainetdinov et al. PHARMACOLOGICAL REVIEWS
- Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine
- (2018) Margherita Fabbri et al. MOVEMENT DISORDERS
- Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates
- (2018) Maude Beaudoin-Gobert et al. NEUROIMAGE
- Diverse serotonin actions of vilazodone reduce l-3,4-dihidroxyphenylalanine-induced dyskinesia in hemi-parkinsonian rats
- (2018) Samantha M. Meadows et al. MOVEMENT DISORDERS
- Interactions of the tricyclic antidepressant drug amitriptyline with L-DOPA in the striatum and substantia nigra of unilaterally 6-OHDA-lesioned rats. Relevance to motor dysfunction in Parkinson's disease
- (2018) Kinga Kamińska et al. NEUROCHEMISTRY INTERNATIONAL
- Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice
- (2017) Oscar Solís et al. NEUROBIOLOGY OF DISEASE
- Expanding the repertoire of L-DOPA’s actions: A comprehensive review of its functional neurochemistry
- (2017) Philippe De Deurwaerdère et al. PROGRESS IN NEUROBIOLOGY
- Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
- (2017) Cristina Miguelez et al. Frontiers in Cellular Neuroscience
- Chronic exposure to dopamine agonists affects the integrity of striatal D 2 receptors in Parkinson's patients
- (2017) Marios Politis et al. NeuroImage-Clinical
- Inhibiting Lateral Habenula Improves L-DOPA–Induced Dyskinesia
- (2016) Matthieu F. Bastide et al. BIOLOGICAL PSYCHIATRY
- 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA
- (2016) Masato Asanuma et al. BMC NEUROSCIENCE
- The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats
- (2016) C Miguelez et al. BRITISH JOURNAL OF PHARMACOLOGY
- L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo
- (2016) Cristina Miguelez et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in L-DOPA-Induced Dyskinesia in Parkinsonian Rats
- (2016) D. Lindenbach et al. JOURNAL OF NEUROSCIENCE
- The novel 5-HT 1A receptor agonist, NLX-112 reduces l -DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements
- (2016) Andrew C. McCreary et al. NEUROPHARMACOLOGY
- Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory
- (2016) Kimberly A. Kempadoo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
- (2016) Giuseppe Di Giovanni et al. Frontiers in Neuroscience
- Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate
- (2015) Maude Beaudoin-Gobert et al. BRAIN
- Could the serotonin theory give rise to a treatment for levodopa-induced dyskinesia in Parkinson’s disease?
- (2015) Erwan Bezard et al. BRAIN
- Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
- (2015) Thomas Müller DRUGS
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat
- (2015) H. Iderberg et al. EXPERIMENTAL NEUROLOGY
- Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission
- (2015) A. Alvarsson et al. JOURNAL OF NEUROSCIENCE
- Gene Expression Analyses Identify Narp Contribution in the Development of L-DOPA-Induced Dyskinesia
- (2015) F. Charbonnier-Beaupel et al. JOURNAL OF NEUROSCIENCE
- Activity of serotonin 5-HT1A receptor ‘biased agonists’ in rat models of Parkinson's disease and l-DOPA-induced dyskinesia
- (2015) H. Iderberg et al. NEUROPHARMACOLOGY
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- Behavioral impairments and serotonin reductions in rats after chronic L-dopa
- (2015) Branden J. Stansley et al. PSYCHOPHARMACOLOGY
- Noradrenergic Terminals Regulatel-DOPA-derived Dopamine Extracellular Levels in a Region-dependent Manner in Parkinsonian Rats
- (2014) Sylvia Navailles et al. CNS Neuroscience & Therapeutics
- L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum
- (2014) Yong Wang et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr
- (2014) Andrew J. Lees et al. MOVEMENT DISORDERS
- Serotonergic pharmacology in animal models: From behavioral disorders to dyskinesia
- (2014) Maude Beaudoin-Gobert et al. NEUROPHARMACOLOGY
- Neurons expressing individual enzymes of dopamine synthesis in the mediobasal hypothalamus of adult rats: Functional significance and topographic interrelations
- (2014) M. Ugrumov et al. NEUROSCIENCE
- Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease
- (2014) Gurdal Sahin et al. PLoS One
- L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum
- (2014) Gregory Porras et al. Scientific Reports
- Multisite Intracerebral Microdialysis to Study the Mechanism of L-DOPA Induced Dopamine and Serotonin Release in the Parkinsonian Brain
- (2013) S. Navailles et al. ACS Chemical Neuroscience
- The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex
- (2013) Paola Devoto et al. ADDICTION BIOLOGY
- Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation
- (2013) O Sader-Mazbar et al. BRITISH JOURNAL OF PHARMACOLOGY
- The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii
- (2013) Y Hiroshima et al. BRITISH JOURNAL OF PHARMACOLOGY
- Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia
- (2013) Matthieu F. Bastide et al. NEUROBIOLOGY OF DISEASE
- Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition
- (2013) A. Fitoussi et al. NEUROSCIENCE
- The real catecholamine content of secretory vesicles in the CNS revealed by electrochemical cytometry
- (2013) Donna M. Omiatek et al. Scientific Reports
- Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD
- (2013) Raúl de la Fuente-Fernández Frontiers in Neurology
- Effects of 3-O-Methyldopa, L-3,4-Dihydroxyphenylalanine Metabolite, on Locomotor Activity and Dopamine Turnover in Rats
- (2012) Yoritaka Onzawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment
- (2012) Stefano Espinoza et al. CNS & Neurological Disorders-Drug Targets
- Axon degeneration in Parkinson's disease
- (2012) Robert E. Burke et al. EXPERIMENTAL NEUROLOGY
- In vivo catecholaminergic metabolism in the medial prefrontal cortex of ENU2 mice: an investigation of the cortical dopamine deficit in phenylketonuria
- (2012) Tiziana Pascucci et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Contribution of Serotonergic Transmission to the Motor and Cognitive Effects of High-Frequency Stimulation of the Subthalamic Nucleus or Levodopa in Parkinson’s Disease
- (2012) Sylvia Navailles et al. MOLECULAR NEUROBIOLOGY
- l-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats
- (2012) C. Miguelez et al. NEUROPHARMACOLOGY
- Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia
- (2011) Nina Nevalainen et al. JOURNAL OF NEUROCHEMISTRY
- The locus coeruleus Is Directly Implicated in L-DOPA-Induced Dyskinesia in Parkinsonian Rats: An Electrophysiological and Behavioural Study
- (2011) Cristina Miguelez et al. PLoS One
- Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia
- (2011) Sylvia Navailles et al. Parkinsons Disease
- Replacing a Dopamine Agonist by the COMT-Inhibitor Tolcapone as an Adjunct to l-dopa in the Treatment of Parkinson's Disease
- (2010) Vincent Ries et al. CLINICAL NEUROPHARMACOLOGY
- High-Frequency Stimulation of the Subthalamic Nucleus and L-3,4-Dihydroxyphenylalanine Inhibit In Vivo Serotonin Release in the Prefrontal Cortex and Hippocampus in a Rat Model of Parkinson's Disease
- (2010) S. Navailles et al. JOURNAL OF NEUROSCIENCE
- Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study
- (2010) Marios Politis et al. NEUROBIOLOGY OF DISEASE
- Serotonergic neurons mediate ectopic release of dopamine induced by l-DOPA in a rat model of Parkinson's disease
- (2010) Sylvia Navailles et al. NEUROBIOLOGY OF DISEASE
- Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease
- (2010) Sylvia Navailles et al. NEUROBIOLOGY OF DISEASE
- Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of l-DOPA treatment
- (2010) Karen L. Eskow Jaunarajs et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Binding of dopamine and 3-methoxytyramine as l-DOPA metabolites to human α2-adrenergic and dopaminergic receptors
- (2010) Amal Alachkar et al. NEUROSCIENCE RESEARCH
- Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator
- (2010) Tatyana D. Sotnikova et al. PLoS One
- Presynaptic control of serotonin on striatal dopamine function
- (2010) Sylvia Navailles et al. PSYCHOPHARMACOLOGY
- Levodopa: Past, Present, and Future
- (2009) Robert A. Hauser EUROPEAN NEUROLOGY
- Non-dopaminergic neurons partly expressing dopaminergic phenotype: Distribution in the brain, development and functional significance
- (2009) M.V. Ugrumov JOURNAL OF CHEMICAL NEUROANATOMY
- l-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of dyskinesia
- (2009) Hanna S. Lindgren et al. JOURNAL OF NEUROCHEMISTRY
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- Trace amine metabolism in Parkinson's disease: Low circulating levels of octopamine in early disease stages
- (2009) Giovanni D’Andrea et al. NEUROSCIENCE LETTERS
- The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond
- (2009) Mario Herrera-Marschitz et al. PROGRESS IN NEUROBIOLOGY
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
- (2008) A. Munoz et al. BRAIN
- Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague–Dawley rats
- (2008) Laura E. Bianco et al. JOURNAL OF NEUROCHEMISTRY
- 6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex
- (2008) Paola Devoto et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy
- (2008) Lynette C. Daws PHARMACOLOGY & THERAPEUTICS
- L-DOPA Is an Endogenous Ligand for OA1
- (2008) Vanessa M Lopez et al. PLOS BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now